Reefer Sanity
Receipts

Every source, in one place.

72 citations: peer-reviewed studies, federal agencies, laws, and reputable reporting. Click any number on the site to jump here.

Links checked November 14, 2026. A few government and news sites block automated checkers, but they open normally in a browser.

  1. 1
    Peer-reviewed study
    Lachenmeier DW, Rehm J. Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Scientific Reports. 2015;5:8126. doi:10.1038/srep08126
    https://www.nature.com/articles/srep08126
  2. 2
    Peer-reviewed study
    Nutt DJ, King LA, Phillips LD. Drug harms in the UK: a multicriteria decision analysis. The Lancet. 2010;376(9752):1558–1565. PMID 21036393
    https://pubmed.ncbi.nlm.nih.gov/21036393/
  3. 3
    Government data
    Centers for Disease Control and Prevention. Facts About U.S. Deaths from Excessive Alcohol Use.
    https://www.cdc.gov/alcohol/facts-stats/index.html
  4. 4
    Government report
    Esser MB, Sherk A, Liu Y, Naimi TS. Deaths from Excessive Alcohol Use — United States, 2016–2021. MMWR. 2024;73(8):154–161.
    https://www.cdc.gov/mmwr/volumes/73/wr/mm7308a1.htm
  5. 5
    International agency
    World Health Organization. Alcohol — fact sheet (data from the 2024 Global status report on alcohol and health).
    https://www.who.int/news-room/fact-sheets/detail/alcohol
  6. 6
    Peer-reviewed study
    GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016. The Lancet. 2018;392:1015–1035. PMID 30146330
    https://pubmed.ncbi.nlm.nih.gov/30146330/
  7. 7
    Government report
    U.S. Surgeon General. Alcohol and Cancer Risk (Advisory), January 2025.
    https://www.hhs.gov/surgeongeneral/reports-and-publications/alcohol-cancer/index.html
  8. 8
    Peer-reviewed study
    Lopez-Quintero C, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the NESARC. Drug and Alcohol Dependence. 2011;115(1-2):120–130. PMID 21145178
    https://pubmed.ncbi.nlm.nih.gov/21145178/
  9. 9
    Systematic review & meta-analysis
    Leung J, Chan GCK, Hides L, Hall WD. What is the prevalence and risk of cannabis use disorders among people who use cannabis? Addictive Behaviors. 2020;109:106479. PMID 32485547
    https://pubmed.ncbi.nlm.nih.gov/32485547/
  10. 10
    National Academies report
    National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. 2017.
    https://nap.nationalacademies.org/catalog/24625
  11. 11
    National Academies report
    NASEM (2017). Report in brief: Committee's conclusions (one-page list of all ~100 conclusions with evidence grades).
    https://nap.nationalacademies.org/resource/24625/Cannabis_committee_conclusions.pdf
  12. 12
    Government guidance
    Centers for Disease Control and Prevention. Cannabis Health Effects.
    https://www.cdc.gov/cannabis/health-effects/index.html
  13. 13
    Peer-reviewed study
    Reiman A. Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal. 2009;6:35. PMID 19958538
    https://pubmed.ncbi.nlm.nih.gov/19958538/
  14. 14
    Peer-reviewed study
    Lucas P, et al. Reductions in alcohol use following medical cannabis initiation: results from a large cross-sectional survey of medical cannabis patients in Canada. International Journal of Drug Policy. 2020;86:102963. PMID 33068830
    https://pubmed.ncbi.nlm.nih.gov/33068830/
  15. 15
    Peer-reviewed study
    Karoly HC, et al. Effects of cannabis use on alcohol consumption in a sample of treatment-engaged heavy drinkers in Colorado. Addiction. 2021;116(9):2529–2537. PMID 33464670
    https://pubmed.ncbi.nlm.nih.gov/33464670/
  16. 16
    Peer-reviewed review
    Subbaraman MS. Can cannabis be considered a substitute medication for alcohol? Alcohol and Alcoholism. 2014;49(3):292–298. PMID 24402247
    https://pubmed.ncbi.nlm.nih.gov/24402247/
  17. 17
    Peer-reviewed study
    Shover CL, Davis CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. PNAS. 2019;116(26):12624–12626. PMID 31182592
    https://pubmed.ncbi.nlm.nih.gov/31182592/
  18. 18
    Peer-reviewed study
    Wang M, et al. Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using UHPSFC/PDA-MS. Cannabis and Cannabinoid Research. 2016;1(1):262–271. PMID 28861498
    https://pubmed.ncbi.nlm.nih.gov/28861498/
  19. 19
    Peer-reviewed review
    Moreno-Sanz G. Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ9-Tetrahydrocannabinolic Acid A. Cannabis and Cannabinoid Research. 2016;1(1):124–130. PMID 28861488
    https://pubmed.ncbi.nlm.nih.gov/28861488/
  20. 20
    Systematic review & meta-analysis
    Whiting PF, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–2473. PMID 26103030
    https://pubmed.ncbi.nlm.nih.gov/26103030/
  21. 21
    Government guidance
    U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process.
    https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process
  22. 22
    Randomized controlled trial
    Devinsky O, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. New England Journal of Medicine. 2017;376:2011–2020. PMID 28538134
    https://pubmed.ncbi.nlm.nih.gov/28538134/
  23. 23
    Peer-reviewed study
    Meier MH, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. PNAS. 2012;109(40):E2657–E2664. PMID 22927402
    https://pubmed.ncbi.nlm.nih.gov/22927402/
  24. 24
    Systematic review
    Sorensen CJ, et al. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment — a Systematic Review. Journal of Medical Toxicology. 2017;13(1):71–87. PMID 28000146
    https://pubmed.ncbi.nlm.nih.gov/28000146/
  25. 25
    Peer-reviewed review
    Hartman RL, Huestis MA. Cannabis effects on driving skills. Clinical Chemistry. 2013;59(3):478–492. PMID 23220273
    https://pubmed.ncbi.nlm.nih.gov/23220273/
  26. 26
    Government guidance
    Centers for Disease Control and Prevention. Cannabis and Poisoning.
    https://www.cdc.gov/cannabis/health-effects/poisoning.html
  27. 27
    Government guidance
    Health Canada. What you need to know if you choose to consume cannabis. 2019.
    https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/what-you-need-to-know-if-you-choose-to-consume-cannabis.html
  28. 28
    Government guidance
    Centers for Disease Control and Prevention. Cannabis and Pregnancy.
    https://www.cdc.gov/cannabis/health-effects/pregnancy.html
  29. 29
    Federal law
    7 U.S.C. § 1639o — Definitions (hemp), including the 2025 amendment and its effective-date notes.
    https://uscode.house.gov/us/usc/119-142/t7/s1639o/
  30. 30
    Congressional Research Service
    Congressional Research Service. Change to Federal Definition of Hemp and Implications for Federal Enforcement (IN12620).
    https://www.congress.gov/crs-product/IN12620
  31. 31
    Legal analysis
    Womble Bond Dickinson (via JD Supra). Hemp Restrictions Start November 12, 2026, but Key Questions Remain. Nov 13, 2026.
    https://www.jdsupra.com/legalnews/hemp-restrictions-start-november-12-1243411/
  32. 32
    State government guidance
    Iowa HHS. Consumable Hemp — Federal Hemp Law Changes & FAQs (summarizes the Nov 12 and Dec 11, 2026 federal dates).
    https://hhs.iowa.gov/health-prevention/consumable-hemp/consumable-hemp-federal-hemp-law-changes-faqs
  33. 33
    Federal Register
    DOJ final rule: Rescheduling of FDA-Approved Products Containing Marijuana (and marijuana under a state medical license) From Schedule I to Schedule III. 91 FR, April 28, 2026.
    https://www.federalregister.gov/documents/2026/04/28/2026-08176/schedules-of-controlled-substances-rescheduling-of-food-and-drug-administration-approved-products
  34. 34
    Government press release
    U.S. Department of Justice. Justice Department Announces Issuance of Federal Registrations for Medical Marijuana Dispensaries.
    https://www.justice.gov/opa/pr/justice-department-announces-issuance-federal-registrations-medical-marijuana-dispensaries
  35. 35
    Government page
    U.S. Drug Enforcement Administration. Marijuana Rescheduling Regulatory Actions.
    https://www.dea.gov/marijuana-rescheduling-regulatory-actions
  36. 36
    State government guidance
    Tennessee Alcoholic Beverage Commission. Frequently Asked Questions — hemp-derived cannabinoid regulation (Public Chapter 526, 2025).
    https://www.tn.gov/abc/public-information-and-forms/frequently-asked-questions.html
  37. 37
    State legislation
    Tennessee General Assembly. HB1376 / SB1413 (114th GA) — bill history and amendments (became Public Chapter 526).
    https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB1376&ga=114
  38. 38
    News report
    WKRN/WATE. TN law banning THCA products takes full effect July 1 (2026).
    https://www.wate.com/news/tennessee/tennessees-thca-ban-to-take-full-effect-july-1/
  39. 39
    News report
    NewsChannel 5 Nashville. New Tennessee hemp laws take effect July 1 (2026).
    https://www.newschannel5.com/news/state/tennessee/davidson-county/new-tennessee-hemp-laws-take-effect-july-1-causing-some-businesses-to-close-relocate-or-adapt
  40. 40
    State law
    Tenn. Code Ann. § 39-17-418 — Simple possession or casual exchange.
    https://law.justia.com/codes/tennessee/title-39/chapter-17/part-4/section-39-17-418/
  41. 41
    Legal reference
    FindLaw. Tennessee Marijuana Laws.
    https://www.findlaw.com/state/tennessee-law/tennessee-marijuana-laws.html
  42. 42
    Government health reference
    MedlinePlus (U.S. National Library of Medicine). Alcohol withdrawal.
    https://medlineplus.gov/ency/article/000764.htm
  43. 43
    Randomized placebo-controlled trial
    Naftali T, et al. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study. Clinical Gastroenterology and Hepatology. 2013;11(10):1276–1280. PMID 23648372
    https://pubmed.ncbi.nlm.nih.gov/23648372/
  44. 44
    Prospective study
    Bonn-Miller MO, et al. The Long-Term, Prospective, Therapeutic Impact of Cannabis on Post-Traumatic Stress Disorder. Cannabis and Cannabinoid Research. 2022;7(2):214–223. PMID 33998874
    https://pubmed.ncbi.nlm.nih.gov/33998874/
  45. 45
    Systematic review
    Orsolini L, et al. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina. 2019;55(9):525. PMID 31450833
    https://pubmed.ncbi.nlm.nih.gov/31450833/
  46. 46
    Peer-reviewed study (preclinical)
    Nadal X, et al. Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. British Journal of Pharmacology. 2017;174(23):4263–4276. PMID 28853159
    https://pubmed.ncbi.nlm.nih.gov/28853159/
  47. 47
    Peer-reviewed study (preclinical)
    Rock EM, et al. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. British Journal of Pharmacology. 2013;170(3):641–648. PMID 23889598
    https://pubmed.ncbi.nlm.nih.gov/23889598/
  48. 48
    Peer-reviewed study (preclinical, NIH)
    Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants. PNAS. 1998;95(14):8268–8273. PMID 9653176
    https://pubmed.ncbi.nlm.nih.gov/9653176/
  49. 49
    U.S. patent
    U.S. Patent No. 6,630,507 B1, “Cannabinoids as antioxidants and neuroprotectants.” Assignee: United States of America as represented by the Department of Health and Human Services. Granted Oct 7, 2003.
    https://patents.google.com/patent/US6630507
  50. 50
    Peer-reviewed study
    Bradford AC, Bradford WD, Abraham A, Bagwell Adams G. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population. JAMA Internal Medicine. 2018;178(5):667–672. PMID 29610897
    https://pubmed.ncbi.nlm.nih.gov/29610897/
  51. 51
    Peer-reviewed study
    Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. International Journal of Drug Policy. 2017;42:30–35. PMID 28189912
    https://pubmed.ncbi.nlm.nih.gov/28189912/
  52. 52
    Peer-reviewed study
    Lucas P, et al. Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances. Harm Reduction Journal. 2019;16:9. PMID 30691503
    https://pubmed.ncbi.nlm.nih.gov/30691503/
  53. 53
    Peer-reviewed study
    Anderson DM, Rees DI, Sabia JJ, Safford S. Association of Marijuana Legalization With Marijuana Use Among US High School Students, 1993–2019. JAMA Network Open. 2021;4(9):e2124638. PMID 34491352
    https://pubmed.ncbi.nlm.nih.gov/34491352/
  54. 54
    Federal Register
    DOJ/DEA. Schedules of Controlled Substances: Rescheduling of Marijuana (proposed rule). 89 FR 44597, May 21, 2024.
    https://www.federalregister.gov/documents/2024/05/21/2024-11137/schedules-of-controlled-substances-rescheduling-of-marijuana
  55. 55
    Government report
    HHS / FDA. Basis for the Recommendation to Reschedule Marijuana into Schedule III of the Controlled Substances Act (Aug 2023).
    https://www.hhs.gov/sites/default/files/scheduling-recommendation.pdf
  56. 56
    Civil-rights report
    ACLU. A Tale of Two Countries: Racially Targeted Arrests in the Era of Marijuana Reform (2020) — press release.
    https://www.aclu.org/press-releases/new-aclu-report-despite-marijuana-legalization-black-people-still-almost-four-times
  57. 57
    Advocacy-group tally of state data
    Marijuana Policy Project. Cannabis Tax Revenue in States that Regulate Cannabis for Adult Use (compiled from state revenue reports).
    https://www.mpp.org/assets/pdf/issues/legalization/cannabis-tax-revenue-states-regulate-cannabis-adult-use.pdf
  58. 58
    Journalism (PBS)
    PBS FRONTLINE. Marijuana Timeline — “Busted: America's War on Marijuana.”
    https://www.pbs.org/wgbh/pages/frontline/shows/dope/etc/cron.html
  59. 59
    Journalism
    Adams C. The man behind the marijuana ban for all the wrong reasons. CBS News, Nov 17, 2016.
    https://www.cbsnews.com/news/harry-anslinger-the-man-behind-the-marijuana-ban/
  60. 60
    Primary source
    Anslinger HJ, Cooper CR. “Marijuana — Assassin of Youth.” The American Magazine, July 1937 (condensed in Reader's Digest, Feb 1938; transcription at the Schaffer Library).
    https://druglibrary.org/mags/assassinofyouth.htm
  61. 61
    Scholarly history
    Bonnie RJ, Whitebread CH. The Marihuana Conviction: A History of Marihuana Prohibition in the United States — chapter “Nonchalance on Capitol Hill” (1937 hearings and Dr. William Woodward's AMA testimony).
    https://www.drugtext.org/library/cannabis/the-marihuana-conviction/nonchalance-on-capitol-hill
  62. 62
    Journalism
    Sullum J. 50 Years After Nixon's Commission Said Cops Should Stop Busting Pot Users... Reason, Mar 22, 2022 (quotes the 1972 Shafer Commission report).
    https://reason.com/2022/03/22/50-years-after-nixons-commission-said-cops-should-stop-busting-pot-users-the-federal-ban-remains-unchanged/
  63. 63
    Journalism
    Baum D. Legalize It All. Harper's Magazine, April 2016.
    https://harpers.org/archive/2016/04/legalize-it-all/
  64. 64
    Journalism
    CNN. Report: Nixon aide says war on drugs targeted blacks, hippies. Mar 23, 2016 (includes the Ehrlichman family's response).
    https://www.cnn.com/2016/03/23/politics/john-ehrlichman-richard-nixon-drug-war-blacks-hippie
  65. 65
    Journalism
    Ingraham C. A maker of deadly painkillers is bankrolling the opposition to legal marijuana in Arizona. Washington Post, Sep 9, 2016.
    https://www.washingtonpost.com/news/wonk/wp/2016/09/09/a-maker-of-deadly-painkillers-is-bankrolling-the-opposition-to-legal-marijuana-in-arizona/
  66. 66
    Journalism
    Phoenix New Times. Arizona Drug Firm Insys Makes Synthetic Pot Compound, Spends Big to Defeat Legal Pot. 2016.
    https://www.phoenixnewtimes.com/news/arizona-drug-firm-insys-makes-synthetic-pot-compound-spends-big-to-defeat-legal-pot-8628614/
  67. 67
    Government press release
    U.S. Attorney's Office, District of Massachusetts. Founder and Four Executives of Insys Therapeutics Convicted of Racketeering Conspiracy. May 2, 2019.
    https://www.justice.gov/usao-ma/pr/founder-and-four-executives-insys-therapeutics-convicted-racketeering-conspiracy
  68. 68
    Journalism (campaign-finance records)
    WBUR. A Look At The Money For And Against Legalized Marijuana In Mass. Oct 20, 2016.
    https://www.wbur.org/morningedition/2016/10/20/marijuana-ballot-question-money
  69. 69
    Journalism
    New York Magazine. Big Beer Takes on Little Weed at the Ballot Box. Sep 2016.
    https://nymag.com/intelligencer/2016/09/big-beer-takes-on-little-weed-at-the-ballot-box.html
  70. 70
    Journalism (campaign-finance records)
    Fang L. Police and Prison Guard Groups Fight Marijuana Legalization in California. The Intercept, May 18, 2016.
    https://theintercept.com/2016/05/18/ca-marijuana-measure/
  71. 71
    Journalism (lobbying disclosures)
    Fang L. The Top Five Special Interest Groups Lobbying To Keep Marijuana Illegal. Republic Report, 2012.
    https://www.republicreport.org/2012/marijuana-lobby-illegal/
  72. 72
    Government guidance
    National Institute on Drug Abuse. Cannabis (Marijuana) — research topic page (“Is cannabis a gateway drug?”).
    https://nida.nih.gov/research-topics/cannabis-marijuana